Trade Mark Journal No.2026/036 4 September 2026
WO0000001932827 (1,5,42)
Office of origin: European Union Intellectual Property Office (EUIPO)
Date of International Registration:5 May 2026
Date of designation in the UK:
5 May 2026
International priority date claimed: 28 November 2025
(European Union Intellectual Property Office (EUIPO))
(019283591)
- Class 1
- Chemical, biological and analytical preparations, active agents, and/or compositions, in particular containing proteins, polypeptides, peptides, for industrial and scientific applications, other than for medical or veterinary use.
- Class 5
- Diagnostic, therapeutic, biological, chemical, analytical and biochemical preparations, active agents, and/or compositions, in particular containing proteins, polypeptides, peptides, in particular for diagnostic and therapeutic applications, pharmaceutical compositions for the diagnosis and treatment of cancer and eye diseases.
- Class 42
- Scientific, technological and industrial services and research, in particular in the therapeutic, diagnostic, pharmaceutical, analytical or biochemical field; services and research for identification, further development and application of diagnostic, therapeutic, biochemical, pharmaceutical or analytical goods; molecular biological, biotechnological, biochemical or pharmaceutical laboratory services; research and development in the field of medical and veterinary diagnostics and treatment using molecular biological, genetic engineering, biotechnological or biochemical methods, and in the field of identification, screening and development of pharmaceutically active components, and test methods and test kits.
Navigo Proteins GmbH
Representative: isarpatent - Patent- und Rechtsanwälte PartGmbB, Friedrichstrasse 31, 80801 München, GERMANY